Top Story

Dow, Third Point Strike Board Deal

Nov 24 2014 | 1:07pm ET

It seems Dow Chemical just needed a little bit of extra prodding from Third Point.

Just a week after the activist hedge fund launched a new website, excoriating Dow for what it called a series of “broken promises,” the company bowed to Third Point’s demand to add a pair of directors of its choosing.

 

Latest News

Hedge Funds Shed 0.50% As Of Mid-Oct.

Nov 24 2014 | 2:35pm ET

The Greenwich Global Hedge Fund Index was down 0.50% as of mid-October and is now up 2.9% year to date.

GAM Adds Trio To Beef Up Liquid Alternatives Team

Nov 24 2014 | 1:37pm ET

GAM has recently appointed three senior quantitative professionals to the firm’s Alternative Investments Solutions team.

Bain Tops Euro. Fund Target By €1B

Nov 24 2014 | 1:01pm ET

Bain Capital’s fundraising for this year has reached 11 figures, with the closing of its fourth European private-equity fund.

Valeant Boosts Share Buyback After Allergan Defeat

Nov 24 2014 | 1:01pm ET

Following the failure of its joint bid for Allergan Inc. with Pershing Square Capital Management, Valeant Pharmaceuticals International has a few billion dollars lying around. The company said last week that it would hand some of that back to investors.

Martoma Reports To Prison

Nov 24 2014 | 12:59pm ET

Mathew Martoma, the former SAC Capital Advisors portfolio manager convicted in February of insider trading, has begun his nine-year prison term.

Fund Focus: Wainscott Capital Bullish On Biotech

Nov 24 2014 | 10:47am ET

While many hedge funds suffered losses in October’s rough markets, one fund bucked the trend: Wainscott Capital Partners, a global long/short equity hedge fund that focuses primarily on biotech and healthcare investing, gained 1.65% for the month.

More News

In Depth

Q&A: Neil Azous Talks Global Macro Investing

Nov 24 2014 | 12:41pm ET

Neil Azous is the founder and managing member of Rareview Macro, an advisory firm to some of the world’s most influential investors and the publisher of the daily newsletter Sight Beyond Sight. Azous recently sat down with FINalternatives to speak about his latest views on global macro investing.

More Features
Neil AzousNeil Azous
 
 
Bo BrustkernBo Brustkern
 
 
 
 

Sponsored Content

    For Hedge Funds, Mastering Data Is Key To Success

    Nov 4 2014 | 9:45am ET

    Data management is important to every business, but for hedge funds, it is critical. FINalternatives recently asked Peter Sanchez, CEO of Northern Trust Hedge Fund Services, how fund managers can deal with the demands of managing data while at the same time remain transparent and abide by operational best practices. Read more…

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

November 2014 Cover

Building a better market

Reg NMS created a huge bifurcation in equity markets and while much of what has followed has been positive, in terms of lower fees and greater liquidity, many traders would like to see the market come...

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.